BLUE ALKYD ADHESIVE

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: Refer to other MSDS sections for detailed information. EFFECTS FROM ACUTE EXPOSURE: INGESTION: Harmful if swallowed. Causes vomiting, nausea, and diarrhea. May cause severe damage of gastrointestinal tract. Aspiration can be a hazard if this material is swallowed. May cause pulmonary edema. SKIN CONTACT: Causes moderate skin irritation. May cause an allergic skin reaction. May cause a rash and itching of the skin. May cause skin defatting with prolonged exposure. Can dry skin. Contains a component which is a known or suspected skin sensitizer. INHALATION: Causes irritation of the mouth, nose, and throat. Excessive inhalation causes headache, dizziness, nausea and incoordination. Can cause unconsciousness if inhaled. EYE CONTACT: Vapor and/or liquid causes irritation. May cause severe eye irritation. Causes redness and tearing. Causes blurred vision. AGGRAVATED CONDITIONS: Respiratory. Pulmonary disorders. Liver, kidney. Dermal ailments. Central nervous system disorders. Gastrointestinal disorders. Eye ailments. SUBCHRONIC (TARGET ORGAN) Dermatitis. Central nervous system damage. Liver and EFFECTS: kidney damage. Pulmonary edema. Reproductive disorders. Eye damage. Reported to cause embryotoxicity when tested on some laboratory animals. CARCINOGENICITY COMMENT: This product or one of its ingredients present 0.1% or more is listed as a carcinogen or potential carcinogen by NTP, IARC or OSHA. CARCINOGENICITY: Captan: Independent studies conducted by Stauffer Chemical and Chevron found captan to be carcinogenic in laboratory animals after oral administration. IARC, NTP and OSHA have not evaluated captan for carcinogenic potential. Ethyl Benzene: The International Agency for Research on Cancer (IARC) has determined that there is inadequate evidence in humans and sufficient evidence in experimental animals for the carcinogenicity of ethyl benzene. IARC has given ethyl benzene an overall evaluation of 2B possibly carcinogenic to humans. Lead and lead compounds: IARC reports that lead and inorganic lead compounds have sufficient evidence for carcinogenicity to animals, Group 2B. IARC also states that organolead compounds such as organic lead soaps show inadequate evidence for carcinogenicity to animals, Group 3. Code of Regulations 29 CFR 1910.1025 includes organic lead soaps.

Principle Routes of Exposure

Oral. Dermal - skin. Eyes. Inhalation. Absorption through skin. OTHER: None known.